当前位置: 首页 > 医疗版 > 医疗管理 > 医疗改革 > 医保
编号:13545951
中美两国医保预算影响分析研究文献的质量评估(10)
http://www.100md.com 2019年6月15日 《中国药房》 201912
     [85] MEARNS ES,LIANG M,LIMONE BL. Economic analysis and budget impact of clostridial collagenase ointment compared with medicinal honey for treatment of pressure ulcers in the US[J]. Clinicoecon Outcomes Res,2017,16(9):485-494.

    [86] RIZZO,JA,RUDMIK L,MALLOW PJ,et al. Budget impact analysis of bioabsorbable drug-eluting sinus implants following endoscopic sinus surgery[J]. J Med Econ,2016,19(9):829-835.

    [87] HESS LM,CINFIO FN,WETMORE S,et al. Enhancing the budget impact model for institutional use:a tool with practical applications for the hospital oncology pharmacy[J]. Hosp Pharm,2016,51(6):452-460.

    [88] GRAHAM J,MAUSKOPF J,KAWAI K,et al. Budget-impact analysis of alternative herpes zoster vaccine strategies:a U.S. HMO perspective[J]. J Manag Care Spec Ph- arm,2016,22(7):872-888.

    [89] ASCHE CV,CLAY E,KHARITONOVA E,et al. Budge- tary impact of the utilization of buprenorphine/naloxone sublingual film and tablet for medicaid in the United States[J]. J Med Econ,2015,18(8):600-611.

    [90] MARSHALL DA,DOUGLAS PR,DRUMMOND MF,et al. Guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada[J]. Pharmacoeconomics,2008,26(6):477-495.

    [91] 董雅琦,顧佳慧,柳鹏程.医保预算影响分析国际经验研究及对我国的启示[J].中国药房,2018,29(12):1652- 1657.

    (收稿日期:2019-01-21 修回日期:2019-05-15)

    (编辑:孙 冰), 百拇医药(柳鹏程 顾佳慧 白铭钰 董雅琦 林佳儿 林夕涵 吴文思 彭楠 邵蓉 姚文兵)
上一页1 2 3 4 5 6 7 8 9 10


    参见:首页 > 医疗版 > 医疗管理 > 医疗改革 > 医保